Many claudins are dysregulated in a range of cancers, as in the case of the CLDN1 and CLDN2 genes, which are overexpressed in colorectal cancer (Dhawan et al., 2011; Mori et al., 2011; Pope et al., 2014; Wang et al., 2019). This evidence concerns the gene CLDN2 and cancer.